Shijing T, Yinping P, Qiong Y, Deshuai L, Liancai Z, Jun T
Microb Cell Fact. 2024; 23(1):326.
PMID: 39623449
PMC: 11613824.
DOI: 10.1186/s12934-024-02592-x.
Nguyen J, Shaw R, Anakk S
Endocrinology. 2022; 163(11).
PMID: 36130324
PMC: 9761580.
DOI: 10.1210/endocr/bqac155.
Luo L, Han W, Du J, Yang X, Duan M, Xu C
Molecules. 2018; 23(12).
PMID: 30558117
PMC: 6321071.
DOI: 10.3390/molecules23123315.
Lee J, Hyun J, Choi I, Yeom S, Kim S, Jung S
Medicine (Baltimore). 2015; 94(50):e2037.
PMID: 26683912
PMC: 5058884.
DOI: 10.1097/MD.0000000000002037.
Hyun J, Lee H, Kim C, Dong S, Lee S, Ryu J
Gut Liver. 2015; 9(4):547-55.
PMID: 26087862
PMC: 4478000.
DOI: 10.5009/gnl15015.
Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.
Hofmann A, Hagey L
J Lipid Res. 2014; 55(8):1553-95.
PMID: 24838141
PMC: 4109754.
DOI: 10.1194/jlr.R049437.
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.
Porez G, Prawitt J, Gross B, Staels B
J Lipid Res. 2012; 53(9):1723-37.
PMID: 22550135
PMC: 3413216.
DOI: 10.1194/jlr.R024794.
Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
Salen G, Tint G, Eliav B, Deering N, MOSBACH E
J Clin Invest. 1974; 53(2):612-21.
PMID: 11344576
PMC: 301505.
DOI: 10.1172/JCI107596.
The gallstone story.
Dowling R
Ulster Med J. 1998; 67 Suppl 1:20-4.
PMID: 9807950
PMC: 2448928.
Transhepatic topical dissolution of gallbladder stones with MTBE and EDTA. Results, side effects, and correlation with CT imaging.
Janowitz P, Schumacher K, Swobodnik W, Kratzer W, Tudyka J, Wechsler J
Dig Dis Sci. 1993; 38(11):2121-9.
PMID: 8223089
DOI: 10.1007/BF01297094.
Study of the sensitivity and specificity of computerized tomography in the detection of calcified gallstones which appears radiolucent by conventional roentgenography.
Sarva R, Farivar S, Fromm H, Poller W
Gastrointest Radiol. 1981; 6(2):165-7.
PMID: 7250631
DOI: 10.1007/BF01890243.
Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet.
Kupfer R, Maudgal D, Northfield T
Dig Dis Sci. 1982; 27(11):1025-9.
PMID: 7140487
DOI: 10.1007/BF01391750.
Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Meredith T, Williams G, Maton P, Murphy G, SAXTON H, Dowling R
Gut. 1982; 23(5):382-9.
PMID: 7076015
PMC: 1419686.
DOI: 10.1136/gut.23.5.382.
Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
Maudgal D, Kupfer R, Northfield T
Gut. 1982; 23(4):280-4.
PMID: 7076005
PMC: 1419743.
DOI: 10.1136/gut.23.4.280.
Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.
BACHRACH W, Hofmann A
Dig Dis Sci. 1982; 27(9):833-56.
PMID: 7049627
DOI: 10.1007/BF01391378.
Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.
Iser J, Sali A
Drugs. 1981; 21(2):90-119.
PMID: 7009140
DOI: 10.2165/00003495-198121020-00002.
Oral cholelitholysis--cheno versus urso: Japanese experience.
Nakayama F
Dig Dis Sci. 1980; 25(2):129-34.
PMID: 6986241
DOI: 10.1007/BF01308311.
Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid.
Kupfer R, Northfield T
Br J Clin Pharmacol. 1983; 15(1):114-6.
PMID: 6849734
PMC: 1427840.
DOI: 10.1111/j.1365-2125.1983.tb01474.x.
Gall-stone dissolution and recurrence: are we being misled?.
Somerville K, Rose D, Bell G, Ellis W, Knapp D
Br Med J (Clin Res Ed). 1982; 284(6325):1295-7.
PMID: 6803946
PMC: 1498166.
DOI: 10.1136/bmj.284.6325.1295.
Effects of bile acid oxazolines on gallstone formation in prairie dogs.
Cohen B, Singhal A, Stenger R, MCSHERRY C, MOSBACH E
Lipids. 1984; 19(7):515-21.
PMID: 6748868
DOI: 10.1007/BF02534484.
